Microba Life Sciences Limited has completed a $14.5 million capital raise through a placement and share purchase plan. The funds will fuel the company’s ongoing work in microbiome research and development, aiming to strengthen its role in diagnostics, therapeutics, and gut health innovation.
Keep Reading
Add A Comment